Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.
2.

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

Breitner JC, Gau BA, Welsh KA, Plassman BL, McDonald WM, Helms MJ, Anthony JC.

Neurology. 1994 Feb;44(2):227-32.

PMID:
8309563
4.

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study.

Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MM, Hofman A.

Neurology. 1995 Aug;45(8):1441-5.

PMID:
7644037
5.

NSAIDs for the chemoprevention of Alzheimer's disease.

Szekely CA, Town T, Zandi PP.

Subcell Biochem. 2007;42:229-48. Review.

PMID:
17612054
6.

[The possible suppression of Alzheimer's disease by nonsteroidal anti-inflammatory drugs].

de Jong D, Jansen RW, Verbeek MM, Kremer HP.

Ned Tijdschr Geneeskd. 2002 Nov 2;146(44):2074-8. Review. Dutch.

PMID:
12448960
7.

Alzheimer's disease: insights from epidemiology.

McDowell I.

Aging (Milano). 2001 Jun;13(3):143-62. Review.

PMID:
11442298
8.

NSAIDs and incident Alzheimer's disease. The Rotterdam Study.

in 't Veld BA, Launer LJ, Hoes AW, Ott A, Hofman A, Breteler MM, Stricker BH.

Neurobiol Aging. 1998 Nov-Dec;19(6):607-11.

PMID:
10192221
9.
10.

Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.

Halliday G, Robinson SR, Shepherd C, Kril J.

Clin Exp Pharmacol Physiol. 2000 Jan-Feb;27(1-2):1-8. Review.

PMID:
10696521
11.

The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada.

[No authors listed]

Neurology. 1994 Nov;44(11):2073-80.

PMID:
7969962
12.

Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal.

Breitner JC.

Neurobiol Aging. 1996 Sep-Oct;17(5):789-94. Review.

PMID:
8892353
13.

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

Breitner JC, Welsh KA, Helms MJ, Gaskell PC, Gau BA, Roses AD, Pericak-Vance MA, Saunders AM.

Neurobiol Aging. 1995 Jul-Aug;16(4):523-30.

PMID:
8544901
14.

Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study.

Anthony JC, Breitner JC, Zandi PP, Meyer MR, Jurasova I, Norton MC, Stone SV.

Neurology. 2000 Jun 13;54(11):2066-71.

PMID:
10851364
15.

Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review.

Szekely CA, Thorne JE, Zandi PP, Ek M, Messias E, Breitner JC, Goodman SN.

Neuroepidemiology. 2004 Jul-Aug;23(4):159-69. Review.

PMID:
15279021
16.

Meta-analysis: cardiovascular events associated with nonsteroidal anti-inflammatory drugs.

Salpeter SR, Gregor P, Ormiston TM, Whitlock R, Raina P, Thabane L, Topol EJ.

Am J Med. 2006 Jul;119(7):552-9.

PMID:
16828623
18.
19.

Anti-inflammatory drugs: a hope for Alzheimer's disease?

Hüll M, Lieb K, Fiebich BL.

Expert Opin Investig Drugs. 2000 Apr;9(4):671-83. Review.

PMID:
11060701
20.

Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging.

Mackenzie IR, Munoz DG.

Neurology. 1998 Apr;50(4):986-90.

PMID:
9566383

Supplemental Content

Support Center